Immunotherapy for Head and Neck Cancer Treatment
1 Bekeken
• 07/02/23
0
0
insluiten
administrator
abonnees
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties